+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Antibody Fragments Market by Product Type (Diabodies, Fab Fragments, Fab'2 Fragments), Application (Diagnostics, Drug Delivery, Research), End User, Technology, Distribution Channel - Global Forecast 2025-2030- Product Image
Antibody Fragments Market by Product Type (Diabodies, Fab Fragments, Fab'2 Fragments), Application (Diagnostics, Drug Delivery, Research), End User, Technology, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Antibody Fragments Market by Product Type (Diabodies, Fab Fragments, Fab'2 Fragments), Application (Diagnostics, Drug Delivery, Research), End User, Technology, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5665739
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Antibody fragments have become a critical focus within biologics, offering precise molecular targeting and a diverse array of applications across diagnostics, therapeutics, and research. The Antibody Fragments Market is seeing growing investment from life sciences organizations as their need for flexible, targeted solutions accelerates.

Market Snapshot: Growth Trajectory in the Antibody Fragments Market

The Antibody Fragments Market grew from USD 8.07 billion in 2024 to USD 8.43 billion in 2025. It is expected to continue growing at a CAGR of 4.35%, reaching USD 10.42 billion by 2030. This uptrend is supported by advancing protein engineering techniques, diversification in fragment structure, strategic partnerships, and an evolving regulatory landscape. Life science leaders are leveraging these trends to enhance R&D productivity, respond to emerging therapeutic demands, and streamline clinical pipelines.

Scope & Segmentation Across Product, Technology, and Region

  • Product Types: Diabodies (camelid, shark), Fab fragments (chimeric, fully human, humanized, murine), Fab'2 fragments (chimeric, fully human, humanized, murine), nanobodies (camelid, shark), single-chain variable fragments (chimeric, fully human, humanized, murine).
  • Applications: Diagnostics (imaging, in vitro diagnostics, point-of-care testing), drug delivery (gene delivery, targeted drug delivery), research (basic, drug discovery, preclinical), therapeutics (infectious, inflammatory, oncology).
  • Technologies: Hybridoma, molecular cloning, phage display (filamentous, lambda, T7), recombinant technology (bacterial, mammalian, yeast expression).
  • End Users: Academic and research institutes, contract research organizations, diagnostic laboratories, pharmaceutical and biotechnology companies.
  • Distribution Channels: Direct sales, distributors, online sales (company website, third-party e-commerce).
  • Geographic Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (e.g. United Kingdom, Germany, France, UAE, South Africa), Asia-Pacific (e.g. China, India, Japan, Australia, Singapore).
  • Leading Companies: Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Bio-Rad Laboratories, PerkinElmer, QIAGEN N.V., Abcam, GenScript Biotech, Sanofi S.A., MorphoSys AG.

Key Takeaways for Decision-Makers

  • Efficient next-generation protein engineering and recombinant techniques are powering shorter development cycles and expanding the diversity of antibody fragment libraries.
  • Market segmentation reveals distinct clinical value in specialized product formats, including bivalent and bispecific fragments that address emerging therapeutic and diagnostic needs.
  • Regional differences in regulatory frameworks and manufacturing infrastructure are shaping go-to-market strategies, with APAC and EMEA regions accelerating in both production and adoption.
  • Strategic alliances and licensing agreements are central in enabling rapid access to innovative fragment platforms and international market reach.
  • Leaders who invest in digital distribution channels and localized manufacturing can mitigate procurement delays and better respond to volatility in research supply chains.

Tariff Impact on Supply Chains and Commercial Strategies

With the introduction of new United States tariffs in 2025, organizations face increased raw material costs and changing global sourcing dynamics for antibody fragment development. Companies are increasingly emphasizing domestic and nearshore production, revisiting supplier contracts, and prioritizing partnerships that protect against extended lead times and regulatory bottlenecks. Flexible procurement and investment in local capabilities are now key components of risk management.

Methodology & Data Sources

Insights are developed using a mix of in-depth secondary analysis, primary interviews with stakeholders across R&D and procurement, and triangulation from industry data, transaction databases, and clinical registries. This ensures comprehensive, validated, and current coverage of antibody fragment market trends and drivers.

Why This Report Matters for Senior Leadership

  • Identify opportunities for accelerated innovation through technology adoption, segment prioritization, and targeted geographic expansion in the antibody fragments market.
  • Enhance competitive positioning by benchmarking leading strategies involving platform innovation, global partnerships, and supply chain agility.
  • Mitigate market and regulatory risks through granular insight into tariff impacts, evolving regional frameworks, and differentiated commercialization options.

Conclusion

Stakeholders equipped with these insights will position their organizations to maximize value and future-proof their discovery and clinical pipelines. Strategic agility, informed by segment-specific and regional dynamics, remains vital for advancing leadership in the antibody fragments market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising demand for bispecific scFv fragments enabling dual antigen targeting in cancer immunotherapy
5.2. Advances in nanobody engineering to enhance blood-brain barrier penetration for neurodegenerative disease treatment
5.3. Strategic partnerships between biotechs and CDMOs to scale up antibody fragment production via microbial hosts
5.4. Development of half-life extension technologies for antibody fragments using Fc fusion and PEGylation strategies
5.5. Emergence of single-domain antibody fragments as diagnostic imaging agents in point-of-care oncology detection
5.6. Regulatory frameworks evolving to accelerate approval pathways for novel recombinant antibody fragments
5.7. Growth in biosimilar antibody fragment pipelines driven by patent expirations of original biologics
5.8. Integration of AI-driven in silico affinity maturation to optimize antibody fragment binding kinetics and stability
5.9. Shift toward cell-free synthesis platforms for rapid prototyping and high-yield antibody fragment manufacturing
5.10. Uptake of antibody fragment-drug conjugates offering improved tumor selectivity and reduced systemic toxicity
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Antibody Fragments Market, by Product Type
8.1. Introduction
8.2. Diabodies
8.2.1. Camelid
8.2.2. Shark
8.3. Fab Fragments
8.3.1. Chimeric
8.3.2. Fully Human
8.3.3. Humanized
8.3.4. Murine
8.4. Fab'2 Fragments
8.4.1. Chimeric
8.4.2. Fully Human
8.4.3. Humanized
8.4.4. Murine
8.5. Nanobodies
8.5.1. Camelid
8.5.2. Shark
8.6. Single Chain Variable Fragments
8.6.1. Chimeric
8.6.2. Fully Human
8.6.3. Humanized
8.6.4. Murine
9. Antibody Fragments Market, by Application
9.1. Introduction
9.2. Diagnostics
9.2.1. Imaging
9.2.2. In Vitro Diagnostics
9.2.3. Point Of Care Testing
9.3. Drug Delivery
9.3.1. Gene Delivery
9.3.2. Targeted Drug Delivery
9.4. Research
9.4.1. Basic Research
9.4.2. Drug Discovery
9.4.3. Preclinical Research
9.5. Therapeutics
9.5.1. Infectious Diseases
9.5.2. Inflammatory Diseases
9.5.3. Oncology
10. Antibody Fragments Market, by End User
10.1. Introduction
10.2. Academic And Research Institutes
10.3. Contract Research Organizations
10.4. Diagnostic Laboratories
10.5. Pharmaceutical And Biotechnology Companies
11. Antibody Fragments Market, by Technology
11.1. Introduction
11.2. Hybridoma
11.3. Molecular Cloning
11.4. Phage Display
11.4.1. Filamentous Phage
11.4.2. Lambda Phage
11.4.3. T7 Phage
11.5. Recombinant Technology
11.5.1. Bacterial Expression
11.5.2. Mammalian Expression
11.5.3. Yeast Expression
12. Antibody Fragments Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Distributors
12.4. Online Sales
12.4.1. Company Website
12.4.2. Third Party E-Commerce
13. Americas Antibody Fragments Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Antibody Fragments Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Antibody Fragments Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Danaher Corporation
16.3.3. Merck KGaA
16.3.4. Bio-Rad Laboratories, Inc.
16.3.5. PerkinElmer, Inc.
16.3.6. QIAGEN N.V.
16.3.7. Abcam plc
16.3.8. GenScript Biotech Corporation
16.3.9. Sanofi S.A.
16.3.10. MorphoSys AG
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ANTIBODY FRAGMENTS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANTIBODY FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANTIBODY FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ANTIBODY FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ANTIBODY FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ANTIBODY FRAGMENTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ANTIBODY FRAGMENTS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ANTIBODY FRAGMENTS MARKET: RESEARCHAI
FIGURE 26. ANTIBODY FRAGMENTS MARKET: RESEARCHSTATISTICS
FIGURE 27. ANTIBODY FRAGMENTS MARKET: RESEARCHCONTACTS
FIGURE 28. ANTIBODY FRAGMENTS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ANTIBODY FRAGMENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY CAMELID, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY CAMELID, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY SHARK, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY SHARK, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY CHIMERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY CHIMERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY FULLY HUMAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY FULLY HUMAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY HUMANIZED, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY HUMANIZED, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY MURINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY MURINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY FAB'2 FRAGMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY FAB'2 FRAGMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY CHIMERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY CHIMERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY FULLY HUMAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY FULLY HUMAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY HUMANIZED, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY HUMANIZED, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY MURINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY MURINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY FAB'2 FRAGMENTS, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY FAB'2 FRAGMENTS, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY NANOBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY NANOBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY CAMELID, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY CAMELID, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY SHARK, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY SHARK, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY NANOBODIES, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY NANOBODIES, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY SINGLE CHAIN VARIABLE FRAGMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY SINGLE CHAIN VARIABLE FRAGMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY CHIMERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY CHIMERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY FULLY HUMAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY FULLY HUMAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY HUMANIZED, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY HUMANIZED, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY MURINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY MURINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY SINGLE CHAIN VARIABLE FRAGMENTS, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY SINGLE CHAIN VARIABLE FRAGMENTS, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY IN VITRO DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY IN VITRO DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY GENE DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY GENE DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY TARGETED DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY TARGETED DRUG DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY INFLAMMATORY DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY INFLAMMATORY DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY HYBRIDOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY HYBRIDOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY MOLECULAR CLONING, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY MOLECULAR CLONING, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY PHAGE DISPLAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY PHAGE DISPLAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY FILAMENTOUS PHAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY FILAMENTOUS PHAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY LAMBDA PHAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY LAMBDA PHAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY T7 PHAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY T7 PHAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY PHAGE DISPLAY, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY PHAGE DISPLAY, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY RECOMBINANT TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY RECOMBINANT TECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY BACTERIAL EXPRESSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY BACTERIAL EXPRESSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY MAMMALIAN EXPRESSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY MAMMALIAN EXPRESSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY YEAST EXPRESSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY YEAST EXPRESSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY RECOMBINANT TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY RECOMBINANT TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY COMPANY WEBSITE, BY REGION, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY COMPANY WEBSITE, BY REGION, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY THIRD PARTY E-COMMERCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY THIRD PARTY E-COMMERCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY FAB'2 FRAGMENTS, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY FAB'2 FRAGMENTS, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY NANOBODIES, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY NANOBODIES, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY SINGLE CHAIN VARIABLE FRAGMENTS, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY SINGLE CHAIN VARIABLE FRAGMENTS, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY PHAGE DISPLAY, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY PHAGE DISPLAY, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY RECOMBINANT TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY RECOMBINANT TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 186. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 187. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 188. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY FAB'2 FRAGMENTS, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY FAB'2 FRAGMENTS, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY NANOBODIES, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY NANOBODIES, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY SINGLE CHAIN VARIABLE FRAGMENTS, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY SINGLE CHAIN VARIABLE FRAGMENTS, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY PHAGE DISPLAY, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY PHAGE DISPLAY, 2025-2030 (USD MILLION)
TABLE 217. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY RECOMBINANT TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 218. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY RECOMBINANT TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 219. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 222. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 223. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 224. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 225. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 226. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 227. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, 2018-2024 (USD MILLION)
TABLE 228. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, 2025-2030 (USD MILLION)
TABLE 229. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, 2018-2024 (USD MILLION)
TABLE 230. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, 2025-2030 (USD MILLION)
TABLE 231. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY FAB'2 FRAGMENTS, 2018-2024 (USD MILLION)
TABLE 232. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY FAB'2 FRAGMENTS, 2025-2030 (USD MILLION)
TABLE 233. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY NANOBODIES, 2018-2024 (USD MILLION)
TABLE 234. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY NANOBODIES, 2025-2030 (USD MILLION)
TABLE 235. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY SINGLE CHAIN VARIABLE FRAGMENTS, 2018-2024 (USD MILLION)
TABLE 236. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY SINGLE CHAIN VARIABLE FRAGMENTS, 2025-2030 (USD MILLION)
TABLE 237. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 240. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 241. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 242. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 243. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 244. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 245. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 246. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 247. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 250. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 251. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY PHAGE DISPLAY, 2018-2024 (USD MILLION)
TABLE 252. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY PHAGE DISPLAY, 2025-2030 (USD MILLION)
TABLE 253. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY RECOMBINANT TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 254. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY RECOMBINANT TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 255. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 258. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 259. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, 2018-2024 (USD MILLION)
TABLE 262. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, 2025-2030 (USD MILLION)
TABLE 263. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, 2018-2024 (USD MILLION)
TABLE 264. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, 2025-2030 (USD MILLION)
TABLE 265. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY FAB'2 FRAGMENTS, 2018-2024 (USD MILLION)
TABLE 266. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY FAB'2 FRAGMENTS, 2025-2030 (USD MILLION)
TABLE 267. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY NANOBODIES, 2018-2024 (USD MILLION)
TABLE 268. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY NANOBODIES, 2025-2030 (USD MILLION)
TABLE 269. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY SINGLE CHAIN VARIABLE FRAGMENTS, 2018-2024 (USD MILLION)
TABLE 270. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY SINGLE CHAIN VARIABLE FRAGMENTS, 2025-2030 (USD MILLION)
TABLE 271. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 272. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 273. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 274. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 275. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 276. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 277. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 278. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 279. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 280. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 281. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 284. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 285. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY PHAGE DISPLAY, 2018-2024 (USD MILLION)
TABLE 286. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY PHAGE DISPLAY, 2025-2030 (USD MILLION)
TABLE 287. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY RECOMBINANT TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 288. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY RECOMBINANT TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 289. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 292. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 293. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 294. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 295. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, 2018-2024 (USD MILLION)
TABLE 296. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, 2025-2030 (USD MILLION)
TABLE 297. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, 2018-2024 (USD MILLION)
TABLE 298. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, 2025-2030 (USD MILLION)
TABLE 299. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY FAB'2 FRAGMENTS, 2018-2024 (USD MILLION)
TABLE 300. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY FAB'2 FRAGMENTS, 2025-2030 (USD MILLION)
TABLE 301. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY NANOBODIES, 2018-2024 (USD MILLION)
TABLE 302. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY NANOBODIES, 2025-2030 (USD MILLION)
TABLE 303. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY SINGLE CHAIN VARIABLE FRAGMENTS, 2018-2024 (USD MILLION)
TABLE 304. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY SINGLE CHAIN VARIABLE FRAGMENTS, 2025-2030 (USD MILLION)
TABLE 305. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 306. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 307. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 308. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 309. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 310. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 311. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 312. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 313. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 314. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 315. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 316. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 317. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 318. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 319. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY PHAGE DISPLAY, 2018-2024 (USD MILLION)
TABLE 320. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY PHAGE DISPLAY, 2025-2030 (USD MILLION)
TABLE 321. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY RECOMBINANT TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 322. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY RECOMBINANT TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 323. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 324. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 325. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 326. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 327. ARGENTINA ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 328. ARGENTINA ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 329. ARGENTINA ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, 2018-2024 (USD MILLION)
TABLE 330. ARGENTINA ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, 2025-2030 (USD MILLION)
TABLE 331. ARGENTINA ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, 2018-2024 (USD MILLION)
TABLE 332. ARGENTINA ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, 2025-2030 (USD MILLION)
TABLE 333. ARGENTINA ANTIBODY FRAGMENTS MARKET SIZE, BY FAB'2 FRAGMENTS, 2018-2024 (USD MILLION)
TABLE 334. ARGENTINA ANTIBODY FRAGMENTS MARKET SIZE, BY FAB'2 FRAGMENTS, 2025-2030 (USD MILLION)
TABLE 335. ARGENTINA ANTIBODY FRAGMENTS MARKET SIZE, BY NANOBODIES, 2018-2024 (USD MILLION)
TABLE 336. ARGENTINA ANTIBODY FRAGMENTS MARKET SIZE, BY NANOBODIES, 2025-2030 (USD MILLION)
TABLE 337. ARGENTINA ANTIBODY FRAGMENTS MARKET SIZE, BY SINGLE CHAIN VARIABLE FRAGMENTS, 2018-2024 (USD MILLION)
TABLE 338. ARGENTINA ANTIBODY FRAGMENTS MARKET SIZE, BY SINGLE CHAIN VARIABLE FRAGMENTS, 2025-2030 (USD MILLION)
TABLE 339. ARGENTINA ANTIBODY FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABL

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Antibody Fragments market report include:
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Abcam plc
  • GenScript Biotech Corporation
  • Sanofi S.A.
  • MorphoSys AG

Table Information

Report AttributeDetails
No. of Pages195
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 8.43 Billion
Forecasted Market Value ( USD ) by 2030 $ 10.42 Billion
Compound Annual Growth Rate4.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Antibody Fragments - Global Strategic Business Report - Product Image

Antibody Fragments - Global Strategic Business Report

  • Report
  • 176 Pages
  • Global
From
Monoclonal Antibodies Market by Product Type (Fragment, Full Length), Technology (Hybridoma, Phage Display, Recombinant), Source, End User, Application - Global Forecast 2025-2030 - Product Image

Monoclonal Antibodies Market by Product Type (Fragment, Full Length), Technology (Hybridoma, Phage Display, Recombinant), Source, End User, Application - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
FAP Antibodies Market by Product Type (Monoclonal, Polyclonal, Recombinant), Application (Diagnostics, Research, Therapeutics), End User, Technology, Distribution Channel - Global Forecast 2025-2030 - Product Image

FAP Antibodies Market by Product Type (Monoclonal, Polyclonal, Recombinant), Application (Diagnostics, Research, Therapeutics), End User, Technology, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Bispecific Antibodies Market Industry Trends and Global Forecasts to 2035: By Therapeutic Area, Mechanism of Action, Target Antigen, Antibody Format, Key Geographical Regions and Key Players - Product Image

Bispecific Antibodies Market Industry Trends and Global Forecasts to 2035: By Therapeutic Area, Mechanism of Action, Target Antigen, Antibody Format, Key Geographical Regions and Key Players

  • Report
  • 391 Pages
  • Global
From
Monoclonal Antibody Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Monoclonal Antibody Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From

About the Antibody Fragment Market

The Antibody Fragment market within the context of Oncology Drugs is a rapidly growing field of biotechnology. Antibody Fragments are small pieces of antibodies that are used to target and treat cancer cells. They are designed to bind to specific antigens on the surface of cancer cells, allowing them to be targeted and destroyed. Antibody Fragments are also used to deliver drugs directly to cancer cells, increasing the effectiveness of the drug. This technology has been used to develop a variety of cancer treatments, including monoclonal antibodies, bispecific antibodies, and antibody-drug conjugates. The Antibody Fragment market is expected to continue to grow as new treatments are developed and approved. This growth is driven by the increasing prevalence of cancer, as well as the need for more effective treatments. Some companies in the Antibody Fragment market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.